Disclosure Of Fair Value Measurement [Text Block]

Hyloris Pharmaceuticals SA - Filing #3166255

Concept As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
Disclosure of fair value measurement [text block]
Disclosure of fair value measurement of assets [text block]
Disclosure of fair value measurement of assets [abstract]
Disclosure of fair value measurement of assets [line items]
Assets
61,864,000 EUR
63,444,000 EUR
Reconciliation of changes in fair value measurement, assets [abstract]
Disclosure of fair value measurement of liabilities [text block]
Disclosure of fair value measurement of liabilities [abstract]
Disclosure of fair value measurement of liabilities [line items]
Liabilities
6,819,000 EUR
15,388,000 EUR
Reconciliation of changes in fair value measurement, liabilities [abstract]
Disclosure of fair value measurement of equity [text block]
Disclosure of fair value measurement of equity [abstract]
Disclosure of fair value measurement of equity [line items]
Equity
55,045,000 EUR
476,000 EUR
121,513,000 EUR
1,622,000 EUR
64,246,000 EUR
140,000 EUR
4,460,000 EUR
54,805,000 EUR
476,000 EUR
48,056,000 EUR
3,827,000 EUR
103,693,000 EUR
2,391,000 EUR
129,000 EUR
43,226,000 EUR
129,000 EUR
3,827,000 EUR
476,000 EUR
1,814,000 EUR
103,693,000 EUR
59,059,000 EUR
Reconciliation of changes in fair value measurement, entity's own equity instruments [abstract]

Talk to a Data Expert

Have a question? We'll get back to you promptly.